Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
34.36
+0.06 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
34.36
0.00 (0.01%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Astrana Health Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Astrana Health stock has a consensus rating of "Strong Buy" and an average price target of $51.67. The average 1-year stock price forecast is 50.38% higher than the current stock price, while the lowest is $41 (+19.32%) and the highest is $65 (+89.17%).
Price Target: $51.67 (+50.38%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $53 | Buy | Initiates | $53 | +54.25% | Sep 15, 2026 |
| Barclays | Barclays | Buy Maintains $53 | Buy | Maintains | $53 | +54.25% | Aug 28, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $47 → $55 | Buy | Reiterates | $47 → $55 | +60.07% | Aug 11, 2026 |
| BTIG | BTIG | Buy Maintains $65 | Buy | Maintains | $65 | +89.17% | Aug 10, 2026 |
| Needham | Needham | Buy Reiterates $41 | Buy | Reiterates | $41 | +19.32% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
3.98B
from 3.18B
Increased by 25.15%
Revenue Next Year
4.38B
from 3.98B
Increased by 10.10%
EPS This Year
3.07
from 2.12
Increased by 44.48%
EPS Next Year
3.64
from 3.07
Increased by 18.59%
EPS and Forward PE are based on non-GAAP adjusted numbers.